CRISPR Therapeutics AG (CRSP) Tax Provisions (2015 - 2026)
CRISPR Therapeutics AG (CRSP) reported Tax Provisions of $839000.0 for Q1 2026, down 23.73% on a YoY basis from $1.1 million in Q1 2025, and up 398.58% sequentially from -$281000.0 in Q4 2025.
CRISPR Therapeutics AG (CRSP) Tax Provisions (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 12 years of Tax Provisions data on file, last reported at $839000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 23.73% year-over-year to $839000.0; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (down 37.9% YoY), and the FY2025 full-year result was $2.7 million, down 24.2% from the prior year.
- Tax Provisions climbed to $839000.0 in Q1 2026, from -$281000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $6.1 million in Q2 2022 to a low of -$9.5 million in Q4 2022.
- A 5-year average of $568058.8 and a median of $839000.0 in 2026 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 527.48% in 2022, while the deepest fall reached 320.59% in 2022.
- Tracing CRSP's Tax Provisions over 5 years: stood at -$9.5 million in 2022, then soared by 101.98% to $188000.0 in 2023, then surged by 272.34% to $700000.0 in 2024, then tumbled by 140.14% to -$281000.0 in 2025, then jumped by 398.58% to $839000.0 in 2026.
- Business Quant data shows CRSP's Tax Provisions at $839000.0 in Q1 2026, -$281000.0 in Q4 2025, and $619000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.47 Bn | 2.03 Bn | - | 839,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 839,000.00 |
| Dec 31, 2025 | -281,000.00 |
| Sep 30, 2025 | 619,000.00 |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 876,000.00 |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 724,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Sep 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 923,000.00 |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | -9.48 Mn |
| Sep 30, 2022 | -575,000.00 |
| Jun 30, 2022 | 6.10 Mn |
| Mar 31, 2022 | 3.61 Mn |
| Dec 31, 2021 | -2.25 Mn |
| Sep 30, 2021 | -600,000.00 |
| Jun 30, 2021 | 4.14 Mn |